CA 2729 CA 153 Breast Cancer Markers Panel Test
Comprehensive Breast Cancer Monitoring and Detection
The CA 2729 CA 153 Breast Cancer Markers Panel Test represents a significant advancement in breast cancer diagnostics, providing healthcare providers with essential tools for monitoring disease progression, treatment effectiveness, and potential recurrence. This sophisticated panel combines two crucial biomarkers—CA 15-3 and CA 27.29—to deliver comprehensive insights into breast cancer activity within the body.
What This Test Measures and Detects
This specialized panel utilizes advanced CMIA (Chemiluminescent Microparticle Immunoassay) technology to measure:
- CA 15-3 Marker: A glycoprotein antigen that becomes elevated in approximately 80% of metastatic breast cancer cases
- CA 27.29 Marker: A more specific and sensitive marker derived from the MUC-1 gene, providing enhanced detection capabilities
These biomarkers are particularly valuable for tracking disease progression in patients already diagnosed with breast cancer, monitoring treatment response, and detecting potential recurrence before clinical symptoms manifest.
Who Should Consider This Test
Primary Candidates Include:
- Patients currently undergoing breast cancer treatment to monitor therapeutic effectiveness
- Individuals with a personal history of breast cancer for recurrence surveillance
- Women with strong family history of breast cancer or genetic predisposition
- Patients experiencing concerning symptoms such as:
- Unexplained breast lumps or thickening
- Persistent breast pain or discomfort
- Nipple changes, discharge, or inversion
- Skin changes on the breast (redness, dimpling, scaling)
- Women with abnormal mammogram findings requiring further investigation
Clinical Benefits of the Breast Cancer Markers Panel
Early Detection and Monitoring Advantages:
- Treatment Response Assessment: Provides objective data on how well current therapies are working
- Recurrence Detection: Can identify cancer recurrence months before clinical symptoms appear
- Progressive Monitoring: Enables continuous tracking of disease progression over time
- Personalized Care: Helps oncologists tailor treatment plans based on biomarker response
- Peace of Mind: Regular monitoring provides reassurance for patients in remission
Understanding Your Test Results
Interpretation Guidelines:
While your healthcare provider will provide specific interpretation based on your individual circumstances, here’s general guidance:
- Normal Range: Results within established reference ranges typically indicate no active disease progression
- Elevated Levels: Increased marker levels may suggest disease progression, treatment resistance, or recurrence
- Trend Analysis: Multiple tests over time provide the most valuable information about disease trajectory
- Clinical Correlation: Results should always be interpreted alongside imaging studies and clinical examination
It’s important to note that elevated marker levels don’t always indicate cancer progression, as other conditions can sometimes cause temporary increases. Your oncologist will consider your complete clinical picture when interpreting results.
Test Details and Pricing
| Test Component | Price (USD) |
|---|---|
| CA 2729 CA 153 Breast Cancer Markers Panel Test | $326 $450 |
Additional Test Information:
- Sample Type: 2 mL (1 mL minimum) serum from 1 SST tube
- Shipping Requirements: Ship refrigerated or frozen
- Turnaround Time: Sample by 7th of the month; Report after 2-3 weeks
- Pre-test Instructions: Provide brief clinical history
- Testing Methodology: CMIA, Immunoassay
Nationwide Accessibility
We have branches across all major cities in the United States, ensuring convenient access to this important breast cancer screening panel. Our facilities in New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose provide comprehensive diagnostic services with the same high standards of care and accuracy.
Take Control of Your Breast Health Today
Early detection and regular monitoring are crucial components of successful breast cancer management. The CA 2729 CA 153 Breast Cancer Markers Panel provides valuable insights that can significantly impact treatment decisions and outcomes.
Book your test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Our experienced staff will guide you through the simple testing process and ensure you receive your results in a timely manner.
Don’t wait—take proactive steps toward comprehensive breast health monitoring. Early detection saves lives, and regular surveillance provides peace of mind for patients and their families.
